Comparable efficacy and safety of insulin glulisine and insulin lispro when given as part of a basal-bolus insulin regimen in a 26-week trial in pediatric patients with type 1 diabetes
Diabetes Technology and Therapeutics, Volume 13, No. 3, Year 2011